BridgeBio Pharma, through its affiliate QED Therapeutics, and Helsinn Group announced a global collaboration and licensing agreement to further develop and commercialize QED Therapeutics’ FGFR1-3 inhibitor, infigratinib, in oncology and all other indications except for skeletal dysplasias (including achondroplasia). Completion of the agreement is subject to regulatory review and customary closing conditions, which are expected […]
The Pestalozzi team included Nils Harbeke (Partner - Tax, pictured), Oliver Widmer (Partner - Financial Services), Christian Roos (Partner - Corporate Commercial), Severin Etzensperger (Associate - IP & TMT).
Schmid AG energy solutions will start to collaborate on an exclusive basis with Viessmann Italia. According to the contract signed between the two companies, this cooperation will cover the entire Italian market, with the exception
Euronext-listed Solvay, a Belgian global leader in materials, chemicals and solutions, sold its Swiss subsidiary Solvay (Schweiz) AG to Sodi Beteiligungen AG for an undisclosed consideration. Lenz & Staehelin advised Solvay SA and Solvay (Schweiz)
Digital Realty Trust announced that it entered into a business combination agreement with InterXion Holding, a provider of data centre services based in the Netherlands.
